期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
西妥昔单抗联合化疗治疗KRAS基因野生型晚期结直肠癌伴肝转移患者临床效果观察及预后影响因素分析 被引量:15
1
作者 曹玉娟 赵聪 +4 位作者 姚艳红 王德林 杜芳 曹凤 郝龙英 《临床军医杂志》 CAS 2021年第8期883-886,共4页
目的观察西妥昔单抗联合化疗治疗KRAS基因野生型晚期结直肠癌伴肝转移患者的临床效果,并对预后影响因素进行分析。方法回顾性分析北京大学首钢医院自2010年1月至2019年1月收治的96例KRAS基因野生型晚期结直肠癌伴肝转移患者的临床资料... 目的观察西妥昔单抗联合化疗治疗KRAS基因野生型晚期结直肠癌伴肝转移患者的临床效果,并对预后影响因素进行分析。方法回顾性分析北京大学首钢医院自2010年1月至2019年1月收治的96例KRAS基因野生型晚期结直肠癌伴肝转移患者的临床资料。按照治疗方案不同,将患者分入XELOX组(n=63)和联合组(n=33)。XELOX组采用XELOX化疗方案;联合组在XELOX组基础上加用西妥昔单抗。比较两组的治疗效果、生存情况及不良反应发生率;采用Cox比例风险回归模型分析预后影响因素。结果联合组客观反应率、疾病控制率、皮疹发生率均高于XELOX组,差异有统计学意义(P<0.05)。两组中位无进展生存期差异无统计学意义(P>0.05)。联合组中位总生存期长于XELOX组,差异有统计学意义(P<0.05)。淋巴结转移、肿瘤部位、乳酸脱氢酶是患者中位总生存期的独立预后因素(P<0.05)。结论西妥昔单抗联合化疗治疗KRAS基因野生型晚期结直肠癌伴肝转移临床效果显著,可延长患者总生存期,淋巴结转移、肿瘤部位、乳酸脱氢酶是预后的有效预测因素。 展开更多
关键词 西妥昔单抗 化疗 kras基因野生型 结直肠癌 肝转移
下载PDF
Growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line 被引量:3
2
作者 Hong Li Hou-Fa Cao +3 位作者 Jun Wan Yuan Li Mei-Ling Zhu Po Zhao 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第6期934-938,共5页
AIM: To observe the growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line Caco-2. METHODS: Recombinant plasmid pCI-neo-Kras2 with wild type Kras2 open reading frame was constructed. Th... AIM: To observe the growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line Caco-2. METHODS: Recombinant plasmid pCI-neo-Kras2 with wild type Kras2 open reading frame was constructed. The Caco-2 cells were transfected with either pCI-neo or pCI-neo-Kras2 using Lipofectamine 2000. The expression of wild type Kras 2 was examined by Northern blot analysis. And the expression of wild type Kras2 protein was examined by Western blot analysis. The effects of wild-type Kras2 on cell proliferation were analyzed by monotetrazolium (MTT) assay, meanwhile analyses of cell cycle and spontaneous apoptosis rate were carried out by flow cytometry (FCM). RESULTS: The plasmid of pCI-neo-Kras 2 was successfully established. The growth rate of cells transfected with pCI-neo-Kras2 was significantly lower than the control cells transfected with the empty pCI-neo vector (P < 0.05). Cell cycle analysis revealed arrest of the pCI-neo-Kras2 transfected cells in G0/G1 phases, decreased DNA synthesis and decreased fractions of cells in S phase. The proliferative index of cells transfected with pCI-neo-Kras2 was decreased compared with the control cells (49.78% vs 64.21%),while the apoptotic rate of Caco-2 cells with stable Kras 2 expression increased (0.30% vs 0.02%). CONCLUSION: The wild-type Kras2 gene effectively inhibits the growth of the colonic adenocarcinoma cell line Caco-2. 展开更多
关键词 结肠腺癌细胞系 野生型kras2基因 生长抑制 细胞周期 细胞凋亡
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部